These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 21349381)
1. [Epithelial ovarian cancer dysplasia: At last a "precancerous" lesion of the ovary!]. Sabourin JC Ann Pathol; 2011 Feb; 31(1):2. PubMed ID: 21349381 [No Abstract] [Full Text] [Related]
2. [Ovarian epithelial dysplasia: Description of a dysplasia scoring scheme]. Chene G; Dauplat J; Raoelfils I; Bignon YJ; Cayre A; Jaffeux P; Aublet-Cuvelier B; Pomel C; Penault-Llorca F Ann Pathol; 2011 Feb; 31(1):3-10. PubMed ID: 21349382 [TBL] [Abstract][Full Text] [Related]
3. Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer. Dauplat J; Chene G; Pomel C; Dauplat MM; Le Bouëdec G; Mishellany F; Lagarde N; Bignon YJ; Jaffeux P; Aublet-Cuvelier B; Dechelotte P; Pouly JL; Penault-Llorca F Eur J Cancer; 2009 Nov; 45(17):2977-83. PubMed ID: 19822418 [TBL] [Abstract][Full Text] [Related]
4. Differentiation and proliferation related proteins in the epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition. McCluggage WG Histopathology; 2004 Sep; 45(3):298-9. PubMed ID: 15330810 [No Abstract] [Full Text] [Related]
5. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881 [TBL] [Abstract][Full Text] [Related]
6. Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations. Deligdisch L; Gil J; Kerner H; Wu HS; Beck D; Gershoni-Baruch R Cancer; 1999 Oct; 86(8):1544-50. PubMed ID: 10526284 [TBL] [Abstract][Full Text] [Related]
7. Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity. Nieto JJ; Crow J; Sundaresan M; Constantinovici N; Perrett CW; MacLean AB; Hardiman PJ Gynecol Oncol; 2001 Aug; 82(2):344-9. PubMed ID: 11531291 [TBL] [Abstract][Full Text] [Related]
8. Hyperplastic and early neoplastic changes in the ovaries of mice after genic deletion of germ cells. Murphy ED J Natl Cancer Inst; 1972 May; 48(5):1283-95. PubMed ID: 4337905 [No Abstract] [Full Text] [Related]
9. Differences in symptoms between patients with benign and malignant ovarian neoplasms. Attanucci CA; Ball HG; Zweizig SL; Chen AH Am J Obstet Gynecol; 2004 May; 190(5):1435-7. PubMed ID: 15167861 [TBL] [Abstract][Full Text] [Related]
10. Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer. Hermsen BB; von Mensdorff-Pouilly S; Berkhof J; van Diest PJ; Gille JJ; Menko FH; Blankenstein MA; Kenemans P; Verheijen RH J Clin Oncol; 2007 Apr; 25(11):1383-9. PubMed ID: 17416858 [TBL] [Abstract][Full Text] [Related]
11. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. Piek JM; van Diest PJ; Zweemer RP; Jansen JW; Poort-Keesom RJ; Menko FH; Gille JJ; Jongsma AP; Pals G; Kenemans P; Verheijen RH J Pathol; 2001 Nov; 195(4):451-6. PubMed ID: 11745677 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma. Seidman JD; Wang BG Gynecol Oncol; 2007 Jul; 106(1):201-6. PubMed ID: 17477958 [TBL] [Abstract][Full Text] [Related]
13. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies. Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280 [TBL] [Abstract][Full Text] [Related]
14. Ovarian dysplasia. A study of identical twins. Gusberg SB; Deligdisch L Cancer; 1984 Jul; 54(1):1-4. PubMed ID: 6539159 [TBL] [Abstract][Full Text] [Related]
15. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. Salazar H; Godwin AK; Daly MB; Laub PB; Hogan WM; Rosenblum N; Boente MP; Lynch HT; Hamilton TC J Natl Cancer Inst; 1996 Dec; 88(24):1810-20. PubMed ID: 8961970 [TBL] [Abstract][Full Text] [Related]
16. Expression of cell cycle regulatory proteins in ovaries prophylactically removed from Jewish Ashkenazi BRCA1 and BRCA2 mutation carriers: correlation with histopathology. Kerner R; Sabo E; Gershoni-Baruch R; Beck D; Ben-Izhak O Gynecol Oncol; 2005 Nov; 99(2):367-75. PubMed ID: 16051332 [TBL] [Abstract][Full Text] [Related]
18. Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition. Piek JM; Verheijen RH; Menko FH; Jongsma AP; Weegenaar J; Gille JJ; Pals G; Kenemans P; van Diest PJ Histopathology; 2003 Jul; 43(1):26-32. PubMed ID: 12823709 [TBL] [Abstract][Full Text] [Related]
19. [Familial cancer of the ovary. A family with 6 index cases]. de Meeus JB; Bennouna C; Maréchaud M; Plocoste V; Magnin G J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):749-56. PubMed ID: 8308201 [TBL] [Abstract][Full Text] [Related]
20. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]